Kidney Problems and Namenda XR
Namenda XR should be used with caution in patients with kidney disease or reduced kidney function.
The kidneys help remove waste products and certain medications from the bloodstream.
Namenda XR contains memantine, which is primarily eliminated from the body through the kidneys.
When kidney function is reduced, the medication may remain in the bloodstream longer than expected.
This can increase the amount of memantine in the body and raise the risk of side effects, including dizziness, confusion, headache, and excessive sleepiness.
Patients with severe kidney impairment generally require a lower dosage.
Under U.S. prescribing information, the recommended maximum dosage for patients with severe renal impairment is 14 mg once daily.
Your healthcare provider may recommend blood tests to evaluate kidney function before starting treatment or adjusting your dosage.
Tell your healthcare provider if you have kidney disease or reduced kidney function before taking Namenda XR. Do not adjust your dosage without medical guidance.
Seizure Disorders and Epilepsy
Patients with a history of seizures or epilepsy should use Namenda XR under careful medical supervision.
A seizure occurs when abnormal electrical activity in the brain causes sudden changes in movement, awareness, sensation, or consciousness.
Symptoms may include involuntary shaking, muscle stiffness, confusion, or temporary loss of awareness.
Namenda XR works by regulating the activity of NMDA receptors, which are involved in communication between nerve cells.
Because these receptors influence brain activity, additional caution may be appropriate for patients with seizure disorders.
Memantine has not been systematically evaluated in patients with seizure disorders, although seizures have been reported during clinical studies.
Tell your healthcare provider if you have epilepsy, previously experienced seizures, or take medications that may lower the seizure threshold.
Your healthcare provider will review your medical history and determine whether additional monitoring is necessary.
Seek emergency medical attention if you experience a new seizure, a prolonged seizure, or repeated seizures without recovering between episodes.
Bladder Problems and Urinary Tract Obstruction
Tell your healthcare provider if you have bladder problems, difficulty urinating, or a history of urinary tract obstruction before taking Namenda XR.
The urinary tract includes the kidneys, ureters, bladder, and urethra.
These structures work together to produce, store, and remove urine from the body.
Urinary tract obstruction occurs when something interferes with the normal flow of urine.
Possible causes include an enlarged prostate, urinary stones, or certain bladder conditions.
Changes in urine flow or urine acidity may affect how quickly memantine is removed from the body.
In particular, conditions that make urine more alkaline can reduce the elimination of memantine and increase medication exposure.
Your healthcare provider may review your urinary symptoms, kidney function, and other medications before prescribing Namenda XR.
Contact your healthcare provider if you develop difficulty urinating, significant changes in urination, or new bladder symptoms during treatment.
Seek urgent medical attention if you are suddenly unable to urinate, particularly if you also experience severe lower abdominal pain.
Liver Problems and Namenda XR
Patients with liver disease should inform their healthcare provider before starting Namenda XR.
The liver helps process many medications and remove certain substances from the bloodstream.
Although memantine is primarily eliminated through the kidneys, a small amount undergoes metabolism in the liver.
Patients with mild or moderate liver impairment generally do not require routine dosage adjustments.
However, Namenda XR has not been adequately studied in patients with severe liver impairment.
For this reason, your healthcare provider may recommend additional caution when prescribing the medication to patients with advanced liver disease.
The appropriate treatment depends on your overall health, kidney function, and other medications.
Tell your healthcare provider if you have liver disease or impaired liver function before starting Namenda XR.
Pregnancy and Namenda XR
Tell your healthcare provider if you are pregnant, planning to become pregnant, or think you may be pregnant before taking Namenda XR.
There is limited information about the safety of memantine during human pregnancy.
Although animal studies have provided some information about potential developmental risks, these findings cannot fully predict how the medication may affect a developing baby.
Namenda XR is approved for moderate to severe dementia associated with Alzheimer’s disease and is not generally used during pregnancy.
If treatment is being considered during pregnancy, your healthcare provider will assess the potential benefits and risks.
Do not assume that a medication is safe during pregnancy simply because it is prescribed for a chronic medical condition.
Do not start or continue Namenda XR during pregnancy without discussing its safety with your healthcare provider.
Breastfeeding and Namenda XR
Consult your healthcare provider before taking Namenda XR if you are breastfeeding.
It is not known whether memantine passes into human breast milk or how exposure might affect a breastfed infant.
There is also limited information about the medication’s potential effects on milk production.
Because of these uncertainties, your healthcare provider will consider the importance of treatment, the health of your baby, and whether another medication is more appropriate.
If Namenda XR is necessary, your healthcare provider can discuss potential risks and recommend an appropriate feeding plan.
Ask your healthcare provider whether Namenda XR is suitable during breastfeeding before starting or continuing treatment.
Medication Interactions With Namenda XR
Namenda XR may interact with certain prescription medications, over-the-counter products, and supplements.
Some interactions may increase memantine levels in the bloodstream, while others may increase the risk of side effects.
For example, dextromethorphan, a medication found in certain cough suppressants, also affects NMDA receptors.
Combining Namenda XR with other NMDA receptor antagonists, such as dextromethorphan, amantadine, or ketamine, may increase the risk of unwanted neurological effects.
Other medications, including cimetidine and hydrochlorothiazide, may affect how memantine is processed or eliminated. However, these combinations do not always cause clinically significant interactions.
Certain medications or substances that make urine more alkaline may reduce the removal of memantine through the kidneys.
This can increase medication exposure and the risk of adverse effects.
Your healthcare provider may recommend additional monitoring or changes to your medication regimen.
Tell your healthcare provider and pharmacist about all medications, vitamins, and herbal supplements you take before starting Namenda XR.
Dizziness, Drowsiness, and Driving
Namenda XR may cause dizziness, headache, or sleepiness in some patients.
These effects may interfere with activities that require balance, concentration, or coordination.
Dizziness is one of the more commonly reported side effects of Namenda XR.
Some patients may feel lightheaded, unsteady, or less alert than usual.
These symptoms may be more noticeable when treatment begins or after the dosage is increased.
Older adults and patients with Alzheimer’s disease may already have balance or mobility difficulties, which can increase the risk of falls.
Caregivers should watch for changes in walking ability, alertness, or coordination.
Patients who experience dizziness should stand up carefully and avoid moving too quickly.
Do not drive, operate heavy machinery, or perform potentially dangerous activities if Namenda XR causes dizziness, excessive sleepiness, or reduced alertness.
Contact your healthcare provider if these symptoms are persistent or severe.
Heart Disease and Cardiovascular Conditions
Tell your healthcare provider if you have heart disease, high blood pressure, or a history of stroke before taking Namenda XR.
Cardiovascular disease affects the heart and blood vessels and may increase the risk of serious health complications.
Although Namenda XR is not primarily a cardiovascular medication, changes in blood pressure and other heart-related events have been reported during memantine treatment.
Some patients may have existing medical conditions that require additional monitoring.
Your healthcare provider will consider your cardiovascular history, current medications, and overall health when deciding whether Namenda XR is appropriate.
Patients with Alzheimer’s disease may also have difficulty recognizing or explaining new symptoms.
For this reason, caregivers should report unusual dizziness, fainting, chest discomfort, or changes in physical functioning.
Tell your healthcare provider if you have a history of heart disease, stroke, abnormal heart rhythms, or other significant cardiovascular conditions before starting Namenda XR.
Restarting Namenda XR After Several Missed Doses
If you have stopped taking Namenda XR for several consecutive days, contact your healthcare provider before restarting treatment.
Namenda XR is usually started at a low dose and gradually increased to improve tolerability.
The usual starting dose is 7 mg once daily, with increases made at intervals of at least one week when appropriate.
This gradual adjustment allows your body to become accustomed to the medication.
If treatment has been interrupted for several days, restarting at your previous maintenance dose may increase the risk of side effects.
Your healthcare provider may recommend restarting at a lower dosage and gradually increasing it again.
The appropriate approach depends on how long treatment was interrupted, your previous dosage, and your medical condition.
Do not automatically restart Namenda XR at your previous dosage after missing several days of treatment. Contact your healthcare provider for instructions.
High Blood Pressure (Hypertension)
Namenda XR may cause increased blood pressure in some patients, although this is not among its most common side effects.
High blood pressure, also called hypertension, occurs when the force of blood against artery walls remains consistently elevated.
Over time, uncontrolled hypertension can increase the risk of heart disease, stroke, and kidney damage.
Patients with existing hypertension should continue taking their prescribed blood pressure medications while using Namenda XR.
Your healthcare provider may recommend regular blood pressure measurements, particularly if your readings become higher than usual.
Caregivers may need to assist patients with monitoring because Alzheimer’s disease can make it difficult to follow daily health routines.
High blood pressure often causes no noticeable symptoms, so monitoring is important.
Contact your healthcare provider if your blood pressure readings become consistently elevated during Namenda XR treatment.
Seek emergency medical attention if severely elevated blood pressure is accompanied by chest pain, severe headache, difficulty breathing, or sudden neurological symptoms.
Overactive Thyroid (Hyperthyroidism)
Tell your healthcare provider if you have an overactive thyroid or a history of thyroid disease before taking Namenda XR.
An overactive thyroid, also called hyperthyroidism, occurs when the thyroid gland produces excessive amounts of thyroid hormones.
These hormones help regulate metabolism, body temperature, and heart rate.
Symptoms of hyperthyroidism may include rapid heartbeat, nervousness, sweating, unexplained weight loss, and difficulty sleeping.
Some symptoms associated with thyroid disorders can also affect concentration, memory, or mental alertness.
For this reason, thyroid function may be considered when evaluating cognitive symptoms.
However, hyperthyroidism is not an established specific contraindication or major warning for Namenda XR.
There is no clear evidence that memantine routinely worsens thyroid hormone production.
Nevertheless, your healthcare provider should be aware of existing thyroid conditions and any medications used to treat them.
Tell your healthcare provider if you have thyroid disease or take thyroid medication so your complete medical history can be considered during treatment.
Important Safety Reminders When Taking Namenda XR
Namenda XR is used to manage symptoms of moderate to severe Alzheimer’s dementia.
Although it may help support memory, thinking, and everyday functioning, it does not cure Alzheimer’s disease or stop its progression.
Patients with kidney disease, seizure disorders, significant urinary problems, or other serious medical conditions may require additional monitoring.
Caregivers should watch for dizziness, falls, changes in behavior, or unusual symptoms during treatment.
Namenda XR should be taken once daily according to the prescribed dosage.
Do not increase the dose, take extra capsules, or restart treatment after several missed days without appropriate medical guidance.
These precautions are not an exhaustive list of all possible warnings, interactions, or adverse effects associated with Namenda XR. Always follow your healthcare provider’s instructions and consult your pharmacist if you have questions about treatment.
REVIEWS